BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 28831632)

  • 1. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
    Vicini F; Shah C; Whitworth P; Walker M; Shi J
    Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
    [No Abstract]   [Full Text] [Related]  

  • 3. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
    Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
    Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risk of Subclinical Breast Cancer-Related Lymphedema by the Extent of Axillary Surgery and Regional Node Irradiation: A Randomized Controlled Trial.
    Boyages J; Vicini FA; Shah C; Koelmeyer LA; Nelms JA; Ridner SH
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):987-997. PubMed ID: 33127493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing Breast Cancer-Related Lymphedema in High-Risk Patients: The Impact of a Structured Surveillance Protocol Using Bioimpedance Spectroscopy.
    Whitworth PW; Shah C; Vicini F; Cooper A
    Front Oncol; 2018; 8():197. PubMed ID: 29946531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
    Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
    Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Whitworth PW; Cooper A
    Breast J; 2018 Jan; 24(1):62-65. PubMed ID: 29063664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
    Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
    Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for breast cancer related lymphedema.
    Shah C; Vicini F; Beitsch P; Laidley A; Anglin B; Ridner SH; Lyden M
    Lymphology; 2013 Dec; 46(4):184-92. PubMed ID: 25141461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of L-Dex(®) Measurements in Assessing Breast Cancer-Related Lymphedema as Part of Routine Clinical Practice.
    Laidley A; Anglin B
    Front Oncol; 2016; 6():192. PubMed ID: 27656420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
    Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
    Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
    Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
    Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
    Jia M; Pan L; Yang H; Gao J; Guo F
    Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
    Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
    Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
    Ridner SH; Dietrich MS; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder SM; Wagner J; Abramson V; Moore A; Shah C
    Ann Surg Oncol; 2019 Oct; 26(10):3250-3259. PubMed ID: 31054038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation.
    Shah C; Wilkinson JB; Baschnagel A; Ghilezan M; Riutta J; Dekhne N; Balaraman S; Mitchell C; Wallace M; Vicini F
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1095-100. PubMed ID: 22099041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.